Hem › Esophageal adenocarcinom › Pennsylvania › Philadelphia
Kliniska studier för Esophageal adenocarcinom i Philadelphia, PA
8 studier för Esophageal adenocarcinom söker deltagare vid platser i och runt Philadelphia (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RekryterarFas 2/3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi bort
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RekryterarFas 3
- Thomas Jefferson University Hospital, Philadelphia
- Einstein Medical Center Philadelphia, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi bort
- och 2 fler
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
RekryterarFas 2/3
- Alliance Cancer Specialists, PC, Wynnewood · 7 mi bort
- Alliance Cancer Specialists, PC, Media · 12 mi bort
- Alliance Cancer Specialists, PC, Horsham · 16 mi bort
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekryterarFas 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Rekryterar
- University of Pennsylania, Perelman School of Medicine, Philadelphia
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekryterarFas 3
- Research Site, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekryterarFas 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
RekryterarFas 2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Esophageal adenocarcinom-studier i andra städer
- New York City, NY18 studier
- Boston, MA13 studier
- Houston, TX12 studier
- Arlington, VA11 studier
- Nashville, TN11 studier
- Durham, NC10 studier
- Baldwin Park, CA9 studier
- Rochester, MN9 studier
- Jacksonville, FL9 studier
- St. Louis, MO9 studier
- Queens, NY9 studier
- Los Angeles, CA9 studier
Andra studier i Philadelphia
- Cancer (alla typer)59 studier
- Bröstcancer56 studier
- Icke-småcellig lungcancer51 studier
- Metastaserande cancer46 studier
- Prostatacancer44 studier
- Kolorektal cancer44 studier
- Äggstockscancer44 studier
- Lungcancer36 studier
- Akut myeloid leukemi34 studier
- Hjärtsvikt31 studier
- Endometriecancer28 studier
- Depression26 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.